JP2004091491A5 - - Google Patents

Download PDF

Info

Publication number
JP2004091491A5
JP2004091491A5 JP2003310760A JP2003310760A JP2004091491A5 JP 2004091491 A5 JP2004091491 A5 JP 2004091491A5 JP 2003310760 A JP2003310760 A JP 2003310760A JP 2003310760 A JP2003310760 A JP 2003310760A JP 2004091491 A5 JP2004091491 A5 JP 2004091491A5
Authority
JP
Japan
Prior art keywords
ccrc
composition
strain
lactobacillus
lactic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003310760A
Other languages
Japanese (ja)
Other versions
JP2004091491A (en
Filing date
Publication date
Priority claimed from TW091119957A external-priority patent/TWI277651B/en
Application filed filed Critical
Publication of JP2004091491A publication Critical patent/JP2004091491A/en
Publication of JP2004091491A5 publication Critical patent/JP2004091491A5/ja
Pending legal-status Critical Current

Links

Claims (11)

IFN−γ分泌を刺激するために治療的に有効な量で、INF−γ分泌を刺激する乳酸細菌株を含む、アレルギーを処置するための組成物であって、該株は、Lactobacillus plantarum CCRC 12944、Lactobacillus acidophilus株CCRC 14079、Lactobacillus rhamnosus 株CCRC 10940、Lactobacillus paracasei亜種paracasei株CCRC 14023、Lactobacillus delbrueckii亜種bulgaricus株CCRC 12297、Lactobacillus delbrueckii亜種bulgaricus株CCRC 14007、およびLactobacillus delbrueckii亜種bulgaricus株CCRC 14069からなる群より選択され、該株全ては、Food Industry Research and Development Institute(FIRDI)、Hsinchu,Taiwanに寄託されている、組成物。 A composition for treating allergy comprising a lactic acid bacterial strain that stimulates INF-γ secretion in a therapeutically effective amount to stimulate IFN-γ secretion, said strain comprising Lactobacillus plantarum CCRC 12944 , Lactobacillus acidophilus strain CCRC 14079, Lactobacillus rhamnosus strain CCRC 10940, Lactobacillus paracasei subspecies paracasei strain CCRC 14023, Lactobacillus delbrueckii subspecies bulgaricus strain CCRC 12297, Lactobacillus delbrueckii subspecies bulgaricus strain CCRC 14007, and Lactobacillu delbrueckii is selected from the group consisting of subspecies bulgaricus strain CCRC 14069, all strain, Food Industry Research and Development Institute (FIRDI), Hsinchu, have been deposited in Taiwan, composition. 前記乳酸細菌株が、Lactobacillus plantarum CCRC 12944である、請求項に記載の組成物。 The composition of claim 1 , wherein the lactic acid bacterial strain is Lactobacillus plantarum CCRC 12944. 前記乳酸細菌株が、Lactobacillus acidophilus CCRC 14079である、請求項に記載の組成物。 The composition of claim 1 , wherein the lactic acid bacterial strain is Lactobacillus acidophilus CCRC 14079. 前記乳酸細菌株が、Lactobacillus rhamnosus CCRC 10940である、請求項に記載の組成物。 The composition of claim 1 , wherein the lactic acid bacterial strain is Lactobacillus rhamnosus CCRC 10940. 前記乳酸細菌株が、Lactobacillus paracasei亜種paracasei CCRC 14023である、請求項に記載の組成物。 The composition of claim 1 , wherein the lactic acid bacterial strain is Lactobacillus paracasei subsp. Paracasei CCRC 14023. 前記乳酸細菌株が、Lactobacillus delbrueckii亜種bulgaricus CCRC 12297である、請求項に記載の組成物。 The composition of claim 1 , wherein the lactic acid bacterial strain is Lactobacillus delbrueckii subsp. Bulgaricus CCRC 12297. 前記乳酸細菌株が、Lactobacillus delbrueckii亜種bulgaricus CCRC 14007である、請求項に記載の組成物。 The composition of claim 1 , wherein the lactic acid bacteria strain is Lactobacillus delbrueckii subsp. Bulgaricus CCRC 14007. 前記乳酸細菌株が、Lactobacillus delbrueckii亜種bulgaricus CCRC 14069である、請求項に記載の組成物。 The composition of claim 1 , wherein the lactic acid bacterial strain is Lactobacillus delbrueckii subsp. Bulgaricus CCRC 14069. 前記乳酸細菌株が、生きているかまたは不活性化されている、請求項に記載の組成物。 The composition of claim 1 , wherein the lactic acid bacterial strain is alive or inactivated. 前記乳酸細菌株が、不活性化されている、請求項に記載の組成物。 The composition according to claim 9 , wherein the lactic acid bacterial strain is inactivated. 薬学的組成物、栄養補助食品、食物、またはこれらの成分の形態である、請求項に記載の組成物。 The composition of claim 1 in the form of a pharmaceutical composition, dietary supplement, food, or an ingredient thereof.
JP2003310760A 2002-09-02 2003-09-02 New application of some lactobacillus strains in allergy treatment Pending JP2004091491A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW091119957A TWI277651B (en) 2002-09-02 2002-09-02 New use of some lactobacillus strains in treating allergy

Publications (2)

Publication Number Publication Date
JP2004091491A JP2004091491A (en) 2004-03-25
JP2004091491A5 true JP2004091491A5 (en) 2005-05-26

Family

ID=32067572

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003310760A Pending JP2004091491A (en) 2002-09-02 2003-09-02 New application of some lactobacillus strains in allergy treatment

Country Status (2)

Country Link
JP (1) JP2004091491A (en)
TW (1) TWI277651B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004233658B2 (en) * 2003-03-13 2009-10-29 Kirin Holdings Kabushiki Kaisha Antiallergic composition
AU2006219475B8 (en) 2005-03-03 2013-02-07 Meiji Co., Ltd. Immune function modulating agents
JP2006273783A (en) * 2005-03-30 2006-10-12 Musashino Seiyaku Kk Composition for prevention and/or treatment of pruritus
KR100745013B1 (en) 2006-01-25 2007-08-10 주식회사 알엔에이 Lactic acid bacteria preventing and treating allergic diseases
TWI356680B (en) * 2007-01-05 2012-01-21 Promd Biotech Co Ltd Anti-allergy lactic acid bacteria
TWI386163B (en) * 2007-01-05 2013-02-21 Promd Biotech Co Ltd Anti-allergy lactic acid bacteria
KR101075557B1 (en) * 2008-12-03 2011-10-20 씨제이제일제당 (주) Novel Lactobacillus plantarum and compositions comprising the same
KR101255050B1 (en) * 2009-07-14 2013-04-16 씨제이제일제당 (주) Novel lactobacillus plantarum and compositions comprising the same
KR101486999B1 (en) * 2009-07-22 2015-01-28 씨제이제일제당 주식회사 Novel lactobacillus plantarum and compositions comprising the same
KR101178217B1 (en) * 2009-10-28 2012-09-07 씨제이제일제당 (주) Novel lactobacillus plantarum and compositions comprising the same
TWI453281B (en) * 2012-03-28 2014-09-21 New Bellus Entpr Co Ltd Anti-allergy lactic acid bacteria and the composition thereof

Similar Documents

Publication Publication Date Title
Maragkoudakis et al. Probiotic potential of Lactobacillus strains isolated from dairy products
Blum et al. Adhesion studies for probiotics: need for validation and refinement
Kalantzopoulos Fermented products with probiotic qualities
EA200800913A1 (en) Effect of probiotics on fat metabolism and obesity
JP6876705B2 (en) Functional hydrated hyaluronic acid and a method for producing coated lactic acid bacteria using it, which has excellent intestinal mucosal adhesion and selective antagonistic activity.
WO2003080813A3 (en) Lactobacillus strains
CA2449403A1 (en) Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
EP1759597A3 (en) Probiotic composition
JP2004091491A5 (en)
JP2002537865A5 (en)
WO2012062780A1 (en) Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
RU2012140052A (en) COMPOSITION CONTAINING PROBIOTIC BACTERIA FOR USE IN THE TREATMENT OF IMMUNE DISORDERS
RU2005104950A (en) Probiotics for the neuromuscular function of the intestine
HRP20160945T1 (en) A method of inducing tolerance to an allergen
CN109771470A (en) A kind of composition and preparation method thereof containing probiotics
Ganguly et al. Effect of whey-pearl millet-barley based probiotic beverage on Shigella-induced pathogenicity in murine model
RU2013126609A (en) EXTRUDED NON-REPLICATING PROBIOTIC MICRO-ORGANISMS AND THEIR HEALTH BENEFITS
JP2008539776A5 (en)
Lee et al. In vitro evaluation of antibacterial activities and anti-inflammatory effects of Bifidobacterium spp. addressing acne vulgaris
Kalra et al. Probiotics and oral health
Kabiri et al. Inhibitiory properties of cytoplasmic extract of Lactobacilli isolated from common carp intestine on human chronic myelocytic leukemia K562 cell line: an in vitro study.
JP4426588B2 (en) Edible olives containing probiotic microorganisms
Tsai et al. Oral administration of multiple lactic acid bacteria strains suppressed allergic responses IgE in an ovalbumin-induced allergy BALB/c mouse model
Manovina et al. Health Benefits of Probiotic Bacteria from Indian Fermented Foods
CA2734327A1 (en) Compositions comprising lactobacillus casei for improving resistance to common infectious diseases